Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lodge

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Plos One|April 28, 2026
Environmental DNA monitoring of waterfowl reveals community changes during migrationLuciana Guimaraes de Andrade, Steve Michael Bogdanowicz, Holger Klinck, et al.
Neurochemistry International|March 22, 2012
A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampusLaura Ceolin, Zuner A Bortolotto, Neil Bannister, et al.
Neuropharmacology|March 27, 2012
Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonistLydia Hanna, Laura Ceolin, Sarah Lucas, et al.
Journal of Neurochemistry|March 11, 2004
In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligandsIlse Smolders, Hilde Lindekens, Ralph Clinckers, et al.
Hippocampus|March 31, 2015
An interchangeable role for kainate and metabotropic glutamate receptors in the induction of rat hippocampal mossy fiber long-term potentiation in vivoJames L Wallis, Mark W Irvine, David E Jane, et al.
International Review of Neurobiology|July 18, 2009
GLUK1 receptor antagonists and hippocampal mossy fiber functionRobert Nisticò, Sheila Dargan, Stephen M Fitzjohn, et al.
Neuropharmacology|August 14, 2016
Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist propertiesHeather Kang, Pojeong Park, Zuner A Bortolotto, et al.
Neuropharmacology|June 10, 2018
Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticityRachael Ingram, Heather Kang, Stafford Lightman, et al.
Neuropharmacology|July 15, 2018
Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expressionChristian M Wood, Keith A Wafford, Andrew P McCarthy, et al.
Journal of Neuroendocrinology|September 3, 2022
Time of day influences stress hormone response to ketamineMatthew T Birnie, Alen V Eapen, Yvonne M Kershaw, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Plos One|April 28, 2026
Environmental DNA monitoring of waterfowl reveals community changes during migrationLuciana Guimaraes de Andrade, Steve Michael Bogdanowicz, Holger Klinck, et al.
Neurochemistry International|March 22, 2012
A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampusLaura Ceolin, Zuner A Bortolotto, Neil Bannister, et al.
Neuropharmacology|March 27, 2012
Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonistLydia Hanna, Laura Ceolin, Sarah Lucas, et al.
Journal of Neurochemistry|March 11, 2004
In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligandsIlse Smolders, Hilde Lindekens, Ralph Clinckers, et al.
Hippocampus|March 31, 2015
An interchangeable role for kainate and metabotropic glutamate receptors in the induction of rat hippocampal mossy fiber long-term potentiation in vivoJames L Wallis, Mark W Irvine, David E Jane, et al.
International Review of Neurobiology|July 18, 2009
GLUK1 receptor antagonists and hippocampal mossy fiber functionRobert Nisticò, Sheila Dargan, Stephen M Fitzjohn, et al.
Neuropharmacology|August 14, 2016
Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist propertiesHeather Kang, Pojeong Park, Zuner A Bortolotto, et al.
Neuropharmacology|June 10, 2018
Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticityRachael Ingram, Heather Kang, Stafford Lightman, et al.
Neuropharmacology|July 15, 2018
Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expressionChristian M Wood, Keith A Wafford, Andrew P McCarthy, et al.
Journal of Neuroendocrinology|September 3, 2022
Time of day influences stress hormone response to ketamineMatthew T Birnie, Alen V Eapen, Yvonne M Kershaw, et al.
Pageof 5